Literature DB >> 15603779

Nucleation of biomimetic apatite in synthetic body fluids: dense and porous scaffold development.

Elena Landi1, Anna Tampieri, Giancarlo Celotti, Ratih Langenati, Monica Sandri, Simone Sprio.   

Abstract

The effectiveness of synthetic body fluids (SBF) as biomimetic sources to synthesize carbonated hydroxyapatite (CHA) powder similar to the biological inorganic phase, in terms of composition and microstructure, was investigated. CHA apatite powders were prepared following two widely experimented routes: (1) calcium nitrate tetrahydrate and diammonium hydrogen phosphate and (2) calcium hydroxide and ortophosphoric acid, but using SBF as synthesis medium instead of pure water. The characteristics of the as-prepared powders were compared, also with the features of apatite powders synthesized via pure water-based classical methods. The powder thermal resistance and behaviour during densification were studied together with the mechanical properties of the dense samples. The sponge impregnation process was used to prepare porous samples having morphological and mechanical characteristics suitable for bone substitution. Using this novel synthesis was it possible to prepare nanosized (approximately equal to 20 nm), pure, carbonate apatite powder containing Mg, Na, K ions, with morphological and compositional features mimicking natural apatite and with improved thermal properties. After sintering at 1250 degrees C the carbonate-free apatite porous samples showed a surprising, high compressive strength together with a biomimetic morphology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15603779     DOI: 10.1016/j.biomaterials.2004.08.010

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

1.  Hybrid structure in PCL-HAp scaffold resulting from biomimetic apatite growth.

Authors:  M Lebourg; J Suay Antón; J L Gomez Ribelles
Journal:  J Mater Sci Mater Med       Date:  2010-01       Impact factor: 3.896

2.  Calcium orthophosphates (CaPO4): occurrence and properties.

Authors:  Sergey V Dorozhkin
Journal:  Prog Biomater       Date:  2015-11-19

3.  Understanding in vivo response and mechanical property variation in MgO, SrO and SiO₂ doped β-TCP.

Authors:  Susmita Bose; Solaiman Tarafder; Shashwat S Banerjee; Neal M Davies; Amit Bandyopadhyay
Journal:  Bone       Date:  2011-03-16       Impact factor: 4.398

4.  MC3T3-E1 cell adhesion to hydroxyapatite with adsorbed bone sialoprotein, bone osteopontin, and bovine serum albumin.

Authors:  Matthew T Bernards; Chunlin Qin; Shaoyi Jiang
Journal:  Colloids Surf B Biointerfaces       Date:  2008-02-08       Impact factor: 5.268

Review 5.  Calcium orthophosphates: occurrence, properties, biomineralization, pathological calcification and biomimetic applications.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Oct-Dec

6.  Hydroxyapatite-chitosan biocomposites synthesized in the simulated body fluid and their drug loading studies.

Authors:  Tugba Basargan; Nalan Erdol-Aydin; Gulhayat Nasun-Saygili
Journal:  J Mater Sci Mater Med       Date:  2017-10-06       Impact factor: 3.896

7.  Biomineralization of a self-assembled extracellular matrix for bone tissue engineering.

Authors:  Yizhi Meng; Yi-Xian Qin; Elaine DiMasi; Xiaolan Ba; Miriam Rafailovich; Nadine Pernodet
Journal:  Tissue Eng Part A       Date:  2009-02       Impact factor: 3.845

8.  Coupling Hydroxyapatite Nanocrystals with Lactoferrin as a Promising Strategy to Fine Regulate Bone Homeostasis.

Authors:  Monica Montesi; Silvia Panseri; Michele Iafisco; Alessio Adamiano; Anna Tampieri
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  A new bioinspired collagen-hydroxyapatite bone graft substitute in adult scoliosis surgery: results at 3-year follow-up.

Authors:  Pietro Giorgi; Dario Capitani; Simone Sprio; Monica Sandri; Anna Tampieri; Valentina Canella; Angelo Nataloni; Giuseppe R Schirò
Journal:  J Appl Biomater Funct Mater       Date:  2017-07-27       Impact factor: 2.604

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.